SANGAMO THERAPEUTICS INC (SGMO) Stock Analyst Earnings Estimates
NASDAQ:SGMO - Nasdaq - US8006771062 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 110.7M -6.35% | 111.3M 0.54% | 176.232M 58.34% | 60.173M -65.86% | 63.765M 5.97% | 101.25M 58.79% | 173.05M 70.91% | 305.39M 76.48% | 516.23M 69.04% | 542.22M 5.03% | 625.09M 15.28% | |
| EBITDA YoY % growth | -173.9M -40.36% | -189.2M -8.80% | -87.527M 53.74% | -95.982M -9.66% | -7.14M 92.56% | 10.251M 243.57% | 146.17M 1,325.91% | 321.71M 120.09% | 550.7M 71.18% | N/A | N/A | |
| EBIT YoY % growth | -183.3M -41.44% | -201.3M -9.82% | -102.592M 49.04% | -107.913M -5.19% | -65.419M 39.38% | -50.289M 23.13% | -18.84M 62.54% | 86.338M 558.26% | 266.83M 209.05% | 270.55M 1.39% | 330.48M 22.15% | |
| Operating Margin | -165.58% | -180.86% | -58.21% | -179.34% | -102.59% | -49.67% | -10.89% | 28.27% | 51.69% | 49.90% | 52.87% | |
| EPS YoY % growth | -1.24 -33.33% | -1.25 -0.81% | -1.47 -17.60% | -0.48 67.56% | -0.30 37.05% | -0.26 13.11% | 0.09 133.91% | 0.52 492.04% | 0.89 70.47% | 1.10 22.86% | 1.23 12.09% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 72.63% | 0.15 154.78% | -0.13 26.33% | -0.12 -406.00% | -0.13 -42.47% | -0.11 -175.86% | -0.09 32.31% | -0.13 -3.33% | -0.13 3.85% |
| Revenue Q2Q % growth | 13.889M 580.17% | 11.22M 2,232.64% | 32.13M 8,925.28% | 11.73M -76.26% | 26.01M 87.27% | 12.351M 10.08% | 17.863M -44.40% | 11.544M -1.59% | 11.576M -55.49% |
| EBITDA Q2Q % growth | -22.644M 36.39% | -21.726M 51.58% | 19.992M 124.85% | -20.91M -244.24% | 2.448M 110.81% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.4M 59.73% | -23.103M 50.08% | -2.244M 97.30% | -23.205M -318.28% | -10.506M 48.50% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.04 106.78% | -0.03 | 0.07 | 237.26% |
| Q2 2024 Q2Q % growth | -0.18 72.73% | -0.15 | -0.03 | -21.11% |
| Q1 2024 Q2Q % growth | -0.27 -325.00% | -0.22 | -0.05 | -23.84% |
| Q4 2023 Q2Q % growth | -0.34 -6.25% | -0.26 | -0.08 | -30.10% |
| Q3 2023 Q2Q % growth | -0.59 -73.53% | -0.33 | -0.26 | -80.76% |
| Q2 2023 Q2Q % growth | -0.66 -127.59% | -0.35 | -0.31 | -88.94% |
| Q1 2023 Q2Q % growth | 0.12 140.00% | -0.33 | 0.45 | 135.85% |
| Q4 2022 Q2Q % growth | -0.32 -23.08% | -0.37 | 0.05 | 12.85% |
| Q3 2022 Q2Q % growth | -0.34 -3.03% | -0.36 | 0.02 | 6.22% |
| Q2 2022 Q2Q % growth | -0.29 12.12% | -0.36 | 0.07 | 19.40% |
| Q1 2022 Q2Q % growth | -0.30 6.25% | -0.32 | 0.02 | 5.43% |
| Q4 2021 Q2Q % growth | -0.26 10.34% | -0.35 | 0.09 | 26.21% |
| Q3 2021 Q2Q % growth | -0.33 -3,200.00% | -0.34 | 0.01 | 4.00% |
| Q2 2021 Q2Q % growth | -0.33 -26.92% | -0.32 | -0.01 | -3.45% |
| Q1 2021 Q2Q % growth | -0.32 13.51% | -0.30 | -0.02 | -6.84% |
| Q4 2020 Q2Q % growth | -0.29 -514.29% | -0.22 | -0.07 | -33.65% |
| Q3 2020 Q2Q % growth | -0.01 95.83% | -0.25 | 0.24 | 95.95% |
| Q2 2020 Q2Q % growth | -0.26 | 0.07 | -0.33 | -464.15% |
| Q1 2020 Q2Q % growth | -0.37 9.76% | -0.29 | -0.08 | -26.67% |
| Q4 2019 Q2Q % growth | 0.07 | -0.33 | 0.40 | 121.04% |
| Q3 2019 Q2Q % growth | -0.24 | -0.35 | 0.11 | 31.03% |
| Q2 2019 Q2Q % growth | -0.26 | -0.37 | 0.11 | 29.19% |
| Q1 2019 Q2Q % growth | -0.41 | -0.25 | -0.16 | -62.95% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 49.412M 425.77% | 18.302M | 31.11M | 169.98% |
| Q2 2024 Q2Q % growth | 356K -94.79% | 8.425M | -8.069M | -95.77% |
| Q1 2024 Q2Q % growth | 481K -99.70% | 6.788M | -6.307M | -92.91% |
| Q4 2023 Q2Q % growth | 2.042M -92.49% | 8.267M | -6.225M | -75.30% |
| Q3 2023 Q2Q % growth | 9.398M -64.54% | 10.613M | -1.215M | -11.45% |
| Q2 2023 Q2Q % growth | 6.835M -76.75% | 15.129M | -8.294M | -54.82% |
| Q1 2023 Q2Q % growth | 157.957M 460.13% | 24.546M | 133.411M | 543.51% |
| Q4 2022 Q2Q % growth | 27.2M -2.86% | 27.394M | -194K | -0.71% |
| Q3 2022 Q2Q % growth | 26.5M -7.34% | 27.321M | -821K | -3.01% |
| Q2 2022 Q2Q % growth | 29.4M 5.38% | 25.123M | 4.277M | 17.02% |
| Q1 2022 Q2Q % growth | 28.2M 7.22% | 27.831M | 369K | 1.33% |
| Q4 2021 Q2Q % growth | 28M 8.53% | 27.36M | 640K | 2.34% |
| Q3 2021 Q2Q % growth | 28.6M -50.52% | 25.693M | 2.907M | 11.31% |
| Q2 2021 Q2Q % growth | 27.9M 29.17% | 27.014M | 886K | 3.28% |
| Q1 2021 Q2Q % growth | 26.3M 100.76% | 25.146M | 1.154M | 4.59% |
| Q4 2020 Q2Q % growth | 25.8M -53.01% | 32.795M | -6.995M | -21.33% |
| Q3 2020 Q2Q % growth | 57.8M 162.73% | 27.08M | 30.72M | 113.44% |
| Q2 2020 Q2Q % growth | 21.6M 23.43% | 104.76M | -83.16M | -79.38% |
| Q1 2020 Q2Q % growth | 13.1M 61.73% | 23.191M | -10.091M | -43.51% |
| Q4 2019 Q2Q % growth | 54.9M | 15.854M | 39.046M | 246.28% |
| Q3 2019 Q2Q % growth | 22M | 12.408M | 9.592M | 77.30% |
| Q2 2019 Q2Q % growth | 17.5M | 13.856M | 3.644M | 26.30% |
| Q1 2019 Q2Q % growth | 8.1M | 23.567M | -15.467M | -65.63% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.35% | -128.12% | 0.53% | 5.42% |
| Revenue | 30.43% | 4.42% | 0% | 8.63% |